Brief: FDA Clears First Blood Test Used In Diagnosing Alzheimer’s Disease
16/05/2025 18:34
May 16 (Reuters) - FDA: FDA CLEARS FIRST BLOOD TEST USED IN DIAGNOSING ALZHEIMER’S DISEASE FDA: CLEARS LUMIPULSE G PTAU217/ß-AMYLOID 1-42 PLASMA RATIO FOR DIAGNOSING ALZHEIMER'S DISEASE - WEBSITE Further company coverage: 4544.T ((Reuters.Briefs@thomsonreuters.com;))